View Full Paper

Owner Consent Verified
Report 4.7

Interoperability in Metaverse for Pharmaceutical Firms: 2021–2029 Trends

40
Pages
Harvard
Style
~ 42–59 mins
Reading Time
AI IoT FinTech
Abstract

This report investigates “Interoperability in Metaverse for Pharmaceutical Firms: 2021–2029 Trends” using a agent-based simulation. Through a socio-technical lens, the analysis integrates multi-source data to derive a practical decision framework for researchers and practitioners.

Interoperability in Metaverse for Pharmaceutical Firms: 2021–2029 Trends

ABSTRACT
Interoperability in Metaverse for Pharmaceutical Firms: 2021–2029 Trends is unpacked across themes: KPIs, risks, equity, and security. Limitations and future research paths are noted.
1
Related Papers
Browse all
25 Pages 4.8
Explainable AI and Policy And Regulation among Gig Workers — A Comparative Perspective
Impact Open Banking Climate
11 Pages 4.6
Roi And Performance Metrics in Supply Chain Resilience for Retail Banks: 2020–2029 Trends
Open Banking HCI Energy
39 Pages 4.6
Internet of Things and Interoperability among Data Science Teams — A Comparative Perspective
Cloud BioMed Logistics